Senate Moves to Keep Politics Out of Cancer Research Funding
oncodaily - On August 2, 2026, US senators introduced a bipartisan temporary spending bill aimed at keeping the federal government funded. The bill also included a provision that would pause earlier proposed […]
AI Summary: Lawmakers advanced a bipartisan measure designed to delay a controversial OMB grantmaking rule and protect peer‑reviewed cancer research funding from politicized oversight. Scientific groups welcomed the move as a pragmatic step to preserve grant integrity and ensure researchers can continue work without sudden administrative disruptions.
- Clinical leaders defend peer review, oppose politicized funding (3)
- Inclusion and funding roles shaping cancer clinical research (3)
- Senate stalls OMB rule to shield cancer grants (3)
Clinical leaders defend peer review, oppose politicized funding
Inclusion and funding roles shaping cancer clinical research
Senate stalls OMB rule to shield cancer grants
Related Stories
Nobel laureate J. Michael Bishop dies; colleagues remember legacy / 5 months
Healthy eating linked to unexpected lung cancer risk via pesticide exposure / 4 months
Florian Lordick elected ESMO president for 2029–2030 term / 2 months
Multiple cancers rising in young people; researchers probe possible causes / 4 months
Supercentenarians show unusually vigilant cancer‑fighting immune cells / 7 days
E‑cigarette use after quitting linked to higher lung cancer risk / 2 months
AACR names 2026 Distinguished Service Award recipients / 4 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Alzheimer's disease, Pediatric Oncology, Drug Pricing, Novo Nordisk and look for the RSS link.
StackHealth Time Machine